The European School of Multimodality Imaging & Therapy (ESMIT)

AD-LEARN mini-course for Techs and Nurses: The Value and Challenges of Brain SPECT in PET in Neurocognitive Disorders
2025-05-20 13:00 - 2025-05-21 17:00 (Europe/Vienna) | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
The course is designed for Technologists and Nurses to enhance their expertise in applying radiopharmaceuticals for AD and MCI diagnosis in nuclear medicine. Participants will learn radiation protection principles, radiolabelling procedures, and waste management. The program also covers novel PET radiotracers for molecular diagnosis of neurocognitive disorders. Additionally, the course addresses patient and caregiver management and the role of Technologists in operating SPECT and PET equipment for AD and MCI imaging. Led by European experts, the interactive sessions will allow participants to engage in discussions and ask questions, fostering a deeper understanding of the subject.

Register now for the VIRTUAL EXPERIENCEIn case you cannot join us in Vienna, here is your chance to follow the course live online! Register now

Learning Objectives

To gain knowledge about the methods and principles of radiolabelling and waste management with a special focus on radiation protection

To become educated in terms of radiotracers used in neurocognitive disorders diagnostic management

To learn the radiolabelling procedures’ adverse events basics and errors’ prevention

To be informed about the principles and importance of appropriate cooperation between medical professional, patient and their caregiver before, during and after SPECT and PET neurocognitive diseases’ imaging

To understand the roles and responsibilities of Technologists and Nurses in the nuclear medicine neurocognitive diseases’ diagnostic management

To improve the skills in terms of the interdisciplinary medical team collaboration focusing on Technologists/Nurses and other medical specialists’ cooperation.

Target Audience

Technologists and Nurses

ProgrammeView the Programme

Faculty

Markus KӧhnerSpeakerErlangen, Germany

Daniela FonsecaSpeakerLondon, UK

Valentina MautoneSpeakerMeldola, Italy

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee Registration for this course is free, but we will charge a €100 fee to book your seat, which will be reimbursed upon attendance

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

GMP for Radiopharmaceuticals
2025-06-05 09:00 - 2025-06-06 16:00
The GMP guidelines provide minimum requirements that a manufacturer of radiopharmaceuticals must meet to assure that their products are consistently high in quality, from batch to batch, for clinical use.

The Basics of cGMP is a 2 days on-site ESMIT course, providing guidance through EU-cGMP regulation for manufacturing, testing, and quality assurance of radiopharmaceuticals in order to ensure that a manufactured product is safe for human use. Principles regarding facilities, equipment qualification, controlled environmental conditions, processes and methods validation, standard operation procedures and user specific requirement, risk assessment, and specifications will be detailed. Also, the main components of investigational new drug and marketing authorisation dossiers will be discussed.

Register nowThe registration is closed. Please contact us at esmit@eanm.org if you still want to register.

Learning Objectives

General knowledge regarding GMP and cGMP for Radiopharmaceuticals principles and guidelines.

Target Audience

Radiopharmacists and radiochemists in translational research, hospital radiopharmacy and radiopharmaceutical production centres.

ProgrammeView the Programme

Faculty

Dana NiculaeSpeakerBucharest, Romania

Philip ElsingaSpeakerGroningen, Netherlands

Antero AbrunhosaSpeakerCoimbra, Portugal

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Focus on FDG PET/CT in Inflammatory and Infectious Diseases
2025-11-20 09:00 - 2025-11-21 12:30
Inflammation comes from the Latin word inflammare, to ignite or to set on fire – we want to ignite your interest in imaging inflammation and infection.

Inflammatory and infectious diseases can be clinically challenging. Many are systemic with highly variable clinical presentations and sometimes vague and non-specific symptoms and findings. Association with implanted material like artificial heart valves, joint or vascular prostheses may hamper imaging or give rise to non-specific findings.

Although the imaging strategy may still be considered unclarified in some settings, [18F]FDG-PET/CT is now established as a key modality in the diagnostic workup of several inflammatory and infectious diseases. The course aims to provide the participants with an overview of the evidence and practical use of [18F]FDG-PET/CT in suspected inflammation and infection and covers the most well-established indications.

Led by European experts, the sessions mix short overview lectures with interactive sessions to allow participants to engage in discussions and exchange experiences on daily practices with each other and the faculty.

Register nowThe course is fully booked. Please contact us at esmit@eanm.org if you would like to be added to the waiting list!

Learning Objectives

To provide general insights into the use of [18F]FDG PET/CT in suspected or manifest inflammation and infection, e.g. patient preparation and protocols

To provide insights into how and when to use [18F]FDG PET/CT in suspected or manifest specific inflammatory diseases, e.g. vasculitis, polymyalgia rheumatica, other reumatologic diseases, and sarcoidosis

To provide insights into how and when to use [18F]FDG PET/CT in suspected or manifest specific infectious diseases, e.g. fever and inflammation of unknown origin, blood stream infections, osteomyelitis and spondylodiscitis, cardiac and vascular infections

To provide some insights into novel developments with this domain, e.g. FAPI, bacteria-specific tracers, and long axial field of view scanners

To facilitate an open discussion on pro and cons of [18F]FDG PET/CT in suspected or manifest inflammation and infections

Target Audience

Nuclear medicine specialists with basic experience in reading [18F]FDG-PET/CT in inflammatory and infectious diseases.

ProgrammeView the Programme

Faculty

Soren HessSpeakerOdense, Denmark

Olivier GheysensSpeakerBrussels, Belgium

Ayah NawwarSpeakerBristol, UK

Giorgio TregliaSpeakerLugano, Switzerland

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Nuclear Medicine in Breast Cancer Based on FOCUS Meeting 6
2025-12-04 08:00 - 2025-12-05 17:00
Breast cancer is the most relevant cancer in women worldwide. It is the second most frequently diagnosed cancer (after lung cancer) and the first leading cause of cancer-related death in women, being the fourth globally regardless of gender. By 2040, breast cancer is predicted to increase to over 3 million new cases and 1 million deaths per year.

Staging patients with breast cancer is challenging due to its heterogeneous nature and presentation. Imaging is of utmost importance in all clinical settings, particularly, in staging, assessing therapy response, and detecting recurrence. Despite the well-stablished usefulness of radiologic modalities, Nuclear Medicine has demonstrated an important role to play in breast cancer, which has been increasingly supported by strong scientific evidence. Considering the patient’s long survival, the benefits of assessing active tumour in an accurate way, gain major importance in these patient’s care.

The recent equipment and radiopharmaceutical developments have opened the path to improve tumour characterization through several imaging possibilities. Currently, the challenge is to use the correct combination of equipment and tracer at the right time. Furthermore, homogenize imaging and clinical procedures is becoming even more important.

During this course, the highlights from the consensus reached during the multidisciplinary EANM Focus Meeting 6 about Nuclear Medicine diagnostics and therapeutics possibilities will be comprehensively presented and discussed in a close way between the faculty and attendees.

Register nowRegistration is now open, save yourself a seat! Register now

Learning Objectives

To understand breast cancer as a heterogeneous disease, its characteristics and evolution;

To define the role of nuclear medicine techniques in different clinical settings (initial staging, assessing therapy response, and detecting recurrence);

To know the potential usefulness of PET tracers beyond FDG in each breast cancer subtype and use of the evolving PET technology & equipment;

To discuss future diagnostic and treatment approaches with radiopharmaceuticals.

Target Audience

Nuclear Medicine physicians, Radiologists, Medical Oncologists, Radiation Oncologists, Medical students, Residents, Nurses, Nuclear Medicine technologists and Radiographers.

ProgrammeView the Programme

Faculty

Sofia VazSpeakerLisbon, Portugal

Thiemo van NijnattenSpeakerMaastricht, Netherlands

Philipp BackhausSpeakerMünster, Germany

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Dose-Effect Response to Targeted Radionuclide Therapy
2026-03-19 09:00 - 2026-03-20 12:30
This intensive 2-day course bridges the gap between radiobiology, dosimetry, and clinical practice in targeted radionuclide therapy. Designed for early-career nuclear medicine physicians and medical physicists, the programme explores dose-response relationships in the three most commonly used theranostic molecules: somatostatin-ligands for neuroendocrine tumours, PSMA-inhibitors for prostate cancer, and radioiodine for thyroid malignancies.

Through a balanced faculty of radiobiologists, dosimetry experts, and experienced nuclear medicine physicians, participants will gain practical insights into the biological effects of radiation, dosimetry calculation methodologies, and their clinical implementation. The course emphasizes hands-on learning through joint case sessions, interactive workshops, and patient-specific treatment planning exercises.

Format: Lectures, case discussions, interactive workshops, and panel sessions

Register nowRegistration is now open, save yourself a seat! Register now

Learning Objectives

At the end of the two days, participants of the course will be able to:

Explain the fundamental radiobiological principles underlying dose-effect relationships in targeted radionuclide therapy and how they differ from external beam radiotherapy and brachytherapy.

Describe the complete workflow from imaging acquisition to dose calculation and apply core dosimetry concepts to clinical TRT scenarios.

Integrate dosimetry data into clinical decision-making for patient selection, treatment planning, and outcome prediction in targeted radionuclide therapy.

Compare and contrast the clinical applications, dose-response characteristics, and dosimetric considerations for somatostatin-ligand therapy (neuroendocrine tumours), PSMA-inhibitor therapy (prostate cancer), and radioiodine therapy (thyroid disease).

Interpret key clinical trial outcomes and evidence-based data related to dosimetry-guided TRT across the three major theranostic applications.

Design a patient-specific TRT treatment plan incorporating radiobiological principles, dosimetric calculations, and clinical considerations for organ protection and tumour targeting.

Identify the practical challenges and solutions for implementing dosimetry protocols in routine clinical nuclear medicine practice.

Critically evaluate when and how personalized dosimetry can optimize therapeutic outcomes and minimize toxicity in individual patients.

Target Audience

Early-career nuclear medicine doctors and medical physicists

ProgrammeThe programme will come soon. View the Programme

Faculty

SpeakerSpeaker

SpeakerSpeaker

SpeakerSpeaker

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

NEW Department Package: If you send 5 participants from your department, you will get an additional 6th seat for free for this course. Please get in touch with the ESMIT office if this is of interest to you.

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card. Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Nuclear Medicine in FUO/IUO: Why Are Children Different?
2026-04-16 09:00 - 2026-04-17 12:30
More information will come soon.

Register nowRegistration is now open, save yourself a seat! Register now

Learning Objectives

More info will come soon.

Target Audience

More info will come soon.

ProgrammeThe programme will come soon. View the Programme

Faculty

SpeakerSpeaker

SpeakerSpeaker

SpeakerSpeaker

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

NEW Department Package: If you send 5 participants from your department, you will get an additional 6th seat for free for this course. Please get in touch with the ESMIT office if this is of interest to you.

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card. Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Bringing Therapy Radioisotopes into Clinical Radiopharmacy – Some Regulatory Aspects
2026-06-11 09:00 - 2026-06-12 12:30

PET in Multiple Myeloma: Evidences, Applications and Perspectives
2026-07-09 09:00 - 2026-07-10 12:30

Prostate Cancer Theranostics
2026-09-24 09:00 - 2026-09-25 12:30

Biomarker Assessment for an Early Biological Diagnosis of Alzheimer's Disease
2026-11-12 09:00 - 2026-11-13 12:30
More information will come soon.

Register nowRegistration is now open, save yourself a seat! Register now

Learning Objectives

More info will come soon.

Target Audience

More info will come soon.

ProgrammeThe programme will come soon. View the Programme

Faculty

SpeakerSpeaker

SpeakerSpeaker

SpeakerSpeaker

Registration Details

Registration FeeCancellation Policy

Course Fee FREE

Course includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Course does NOT include:

Travel to the Venue

Accommodation

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Focus on Benign Thyroid Disease: From Thyroid Nodule to Hyperthyroidism and Immune Disease
2026-12-03 09:00 - 2026-12-04 12:30
